⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18390208 | 0.89 | LGALS8 (0.30) | — | |
| SCHEMBL16729887 | 0.89 | LGALS8 (0.30) | — | |
| SCHEMBL21561635 | 0.75 | SSTR1 (0.31) | — | |
| SCHEMBL19631498 | 0.74 | LGALS8 (0.33) | — | |
| SCHEMBL13447823 | 0.73 | LGALS8 (0.35) | — | |
| SCHEMBL20334521 | 0.73 | LGALS8 (0.33) | — | |
| SCHEMBL19661469 | 0.73 | LGALS8 (0.33) | — | |
| SCHEMBL12292292 | 0.73 | LGALS8 (0.33) | — | |
| SCHEMBL23417369 | 0.73 | MAPK1 (0.42) | — | |
| SCHEMBL22605123 | 0.73 | MAPK1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013000856-A1 | HCV COMBINATION THERAPY | SANTARIS PHARMA A/S (DK) | 2013-01-03 | — | — | WO | disclosed |